Pneumococcal vaccine reduces serious superbug infections
Pneumococcal vaccine reduces serious superbug infections

Article at a Glance

  • The pneumococcal vaccine is linked with a 62 percent decrease in antibiotic-resistant cases of pneumococcal infections.
  • This vaccine is an important step in preventing the spread of antibiotic-resistant superbugs.
  • The pneumococcal vaccine is recommended for children under five years old, adults 65 or older, or people with health conditions that put them at a higher risk.

Article Types

Archives

Sign up to our Newsletter

  • This field is for validation purposes and should be left unchanged.

Is Your Child Sick?


en español


Stay connected to your children’s health:

Want pediatric news, kid-friendly recipes and parenting tips?
Sign up for our patient parent newsletter:

Other great ways to connect: